BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34066495)

  • 1. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
    Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SnapShot: Medulloblastoma.
    Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
    Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma epigenetics and the path to clinical innovation.
    Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
    J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining the molecular substructure of medulloblastoma.
    Benmaamar R
    Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
    [No Abstract]   [Full Text] [Related]  

  • 5. The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.
    Laneve P; Po A; Favia A; Legnini I; Alfano V; Rea J; Di Carlo V; Bevilacqua V; Miele E; Mastronuzzi A; Carai A; Locatelli F; Bozzoni I; Ferretti E; Caffarelli E
    Oncotarget; 2017 May; 8(19):31003-31015. PubMed ID: 28415684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
    Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
    Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
    Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
    Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA profiling of pediatric Medulloblastoma.
    Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
    BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in medulloblastoma.
    Vidal DO; Marques MM; Lopes LF; Reis RM
    Pediatr Hematol Oncol; 2013 Aug; 30(5):367-78. PubMed ID: 23528184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
    de Haas TG; Kool M
    Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
    Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
    Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
    Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
    Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
    Li YX; Shao LW; Jiang T; Liu Y; Chang Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
    [No Abstract]   [Full Text] [Related]  

  • 15. New Approaches in Targeted Therapy for Medulloblastoma in Children.
    Maier H; Dalianis T; Kostopoulou ON
    Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
    Shiraishi R; Kawauchi D
    Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation in medulloblastoma.
    Yi J; Wu J
    Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellum development and medulloblastoma.
    Roussel MF; Hatten ME
    Curr Top Dev Biol; 2011; 94():235-82. PubMed ID: 21295689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Polkinghorn WR; Tarbell NJ
    Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.